Parvovirus B19 infection and autoimmune disease

Autoimmunity Reviews

Volumn 2, Issue 4, 2003, Pages 218-223

  Lehmann, Hartwig W ^a   Von Landenberg, Philipp ^b   Modrow, Susanne ^c  

^a Sachsisches Krankhs Hubertusburg   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Anti phospholipid syndrome; Arthralgia arthritis; Autoimmune reaction; Juvenile rheumatoid arthritis; Parvovirus B19 infection

Indexed keywords

BETA2 GLYCOPROTEIN 1; HELICASE; INTERLEUKIN 6; PHOSPHOLIPASE A2; PROTEIN SUBUNIT; PROTEIN VP1; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA; VIRUS PROTEIN;

ANEMIA; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLOOD DISEASE; CLINICAL FEATURE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ERYTHEMA INFECTIOSUM; FETUS WASTAGE; FLU LIKE SYNDROME; HEPATITIS; HUMAN; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; MYOSITIS; NEUROLOGIC DISEASE; NONHUMAN; PANCYTOPENIA; PARVOVIRUS; POLYARTHRITIS; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; RASH; REVIEW; THROMBOCYTOPENIA; VASCULITIS; VIREMIA; VIRUS DETECTION; VIRUS INFECTION; VIRUS PATHOGENESIS;

EID: 0038387869     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-9972(03)00014-4     Document Type: Review

References (40)

1. Heegard E.D., Brown K.E. Human parvovirus B19. Clin Microbiol Rev. 15:2002;485-505.
2. Dorsch S., Liebisch G., Kaufmann B., et al. The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J Virol. 76:2002;2014-2018.
3. Raab U., Beckenlehner K., Lowin T., Niller H.H., Doyle S., Modrow S. NS1-protein of parvovirus B19 interacts directly with DNA sequences of the p6-promoter and with cellular transcription factors Sp1/Sp3. Virology. 293:2002;86-93.
4. Fu Y., Ishii K.K., Munakata Y., Saitoh T., Kaku M., Sasaki T. Regulation of tumor necrosis factor alpha promoter by human parvovirus B19 NS1 through activation of AP-1 and AP-2. J Virol. 76:2002;5395-5403.
5. Mitchell L.A. Parvovirus B19 nonstructural (NS1) protein as a transactivator of interleukin-6 synthesis: common pathway in inflammatory sequelae of human parvovirus infection? J Med Virol. 67:2002;267-274.
6. Söderlund M., von Essen R., Haapasaari J., Kiistala U., Kiviluoto O., Hedman K. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet. 349:1997;1063-1065.
7. Cassinotti P., Burtonboy G., Fopp M., Siegl G. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol. 53:1997;229-232.
8. Eis-Hübinger A.M., Reber U., Abdul-Nour T., Glatzel U., Lauschke H., Putz U. Evidence for persistence of parvovirus B19 DNA in livers of adults. J Med Virol. 65:2001;395-401.
9. Cherry J.D. Parvovirus infections in children and adults. Adv Pediatr. 46:1994;245-269.
10. Kurtzman G.J., Ozawa K., Cohen B., et al. Chronic bone marrow failure due to persistent parvovirus B19 infection. N Engl J Med. 317:1987;287-294.
11. Pont J., Puchhammer-Stöckl E., Chott A., et al. Recurrent granulocytoc aplasia as clinical presentation of a persistent parvovirus B19 infection. Br J Haematol. 80:1992;160-165.
12. Modrow S., Dorsch S. Antibody responses in parvovirus B19 infected patients. Pathol Biol. 50:2002;326-331.
13. Naides S.J., Scharosch L.L., Foto F., Howard E.J. Rheumatologic manifestations of human parvovirus B19 infection in adults. Initial two-year clinical experience. Arthritis Rheum. 33:1990;1297-1309.
14. Lehmann H.W., Kühner L., Beckenlehner K., et al. Chronic human parvovirus B19 infection in rheumatic disease of childhood and adolescence. J Clin Virol. 25:2002;135-143.
15. Stahl H.D., Seidl B., Hubner B., et al. High incidence of parvovirus B19 DNA in synovial tissue of patients with undifferentiated mono- and oligoarthritis. Clin Rheumatol. 19:2000;281-286.
16. Stahl H.D., Pfeiffer R., Emmrich F. Intravenous treatment with immunoglobulins may improve chronic undifferentiated mono- and oligoarthritis. Clin Exp Rheumatol. 18:2000;515-517.
17. Moore T.L., Bandlamudi R., Alam S.M., Nesher G. Parvovirus infection mimicking systemic lupus erythematosus in a pediatric population. Semin Arthritis Rheum. 28:1999;314-318.
18. Tovari E., Mezey I., Hedman K., Czirjak L. Self limiting lupus-like symptoms in patients with parvovirus B 19 infection. Ann Rheum Dis. 61:2002;662-663.
19. Hemauer A., Beckenlehner K., Wolf H., Lang B., Modrow S. Acute parvovirus B19 infection in connection with a flare of systemic lupus erythematodes in a female patient. J Clin Virol. 14:1999;73-77.
20. Chakravarty K., Merry P. Systemic vasulitis and atypical infections: report of two cases. Postgrad Med J. 75:1999;544-546.
21. Vargas-Diez E., Buezo G.F., Aragues M., Dauden E., de Ory F. Papular-purpuric gloves-and-socks syndrome. Int J Dermatol. 35:1996;626-632.
22. Nigro G., Zerbini M., Krysztofiak A., et al. Active or recent parvovirus B19 infection in children with Kawasaki disease. Lancet. 343:1994;1260-1261.
23. Chua P.K., Nerurkar V.R.E., Yu Q., Woodward C.L., Melish M.E., Yanagihara R. Lack of association between Kawasaki syndrome and infection with parvovirus B19, human herpesvirus 8, TT virus, GB virus C/Hepatitis G virus or Chlamydia pneumoniae. Pediatr Infect Dis J. 19:2000;477-479.
24. Gabriel S.E., Espy M., Erdman D.D., Bjornsson J., Smith T.F., Hunder G.G. The role of parvovirus B19 in the pathogenesis of giant cell arteritis. Arthritis Rheum. 42:1999;1255-1258.
25. Magro C.M., Crowson A.N., Dawood M., Nuovo G.J. Parvoviral infection of endothelial cells and first possible role in vasculitis and autoimmune diseases. J Rheumatol. 29:2002;1227-1235.
26. Viguier M., Guillevin L., Laroche L. Treatment of parvovirus-associated polyarteritis nodosa with intravenous immune globulin. N Engl J Med. 344:2001;1481-1482.
27. Chevrel G., Calvet A., Belin V., Miossec P. Dermatomyositis associated with the presence of parvovirus B19 DNA in muscle. Rheumatology. 39:2000;1037-1039.
28. Nikkari S., Mertsola J., Korvenranta H., Vainionpaa R., Toivanen P. Wegener's granulomatosis and parvovirus B19 infection. Arthritis Rheum. 37:1994;1174-1175.
29. Scheurlen W., Ramasubbu K., Wachowski O., Hemauer A., Modrow S. Chronic autoimmune thrombopenia/neutropenia in a boy with persistent parvovirus B19 infection. J Clin Virol. 20:2001;173-178.
30. Murray J.C., Kelley P.K., Hogrefe W.R., McClain K.L. Childhood idiopathic purpura: association with human parvovirus B19 infection. Am J Pediatr Hematol Oncol. 16:1994;314-319.
31. Heegard E.D., Rosthoj S., Petersen B.L., Nielsen S., Karup Pedersen F., Hornsleth A. Role of parvovirus B19 infection in childhood idiopathic thrombocytopenic purpura. Acta Paediatr. 88:1999;614-617.
32. McClain K., Estrov Z., Chen H., Mahoney D.H. Jr. Chronic thrombocytopenia of childhood: frequent association with parvovirus infection and correlation with bone marrow culture studies. Br J Haematol. 85:1993;57-62.
33. Bux J., Behrens G., Jaeger G., Welte K. Diagnosis and clinical cause of autoimmune neutropenia on infancy analysis of 240 cases. Blood. 91:1998;181-186.
34. Tomiyama J., Adachi Y., Hanada T., Matsunaga Y. Human parvovirus B19-induced aplastic crisis in autoimmune haemolytic anaemia. Br J Haematol. 62:1988;288-289.
35. Hoang M.P., Dorson D.W., Rogers Z.R., Scheuermann R.H., Rogers B.B. Polymerase chain reaction amplification of archival material for Epstein-Barr-virus, cytomegalovirus, human herpesvirus 6 and parvovirus B19 in children with bone-marrow hemophagocytosis. Hum Pathol. 29:1998;1074-1077.
36. Kerr J.R., Barah F., Mattey D.L., et al. Circulating tumor necrosis factor α and interferon γ are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue. J Gen Virol. 82:2001;3011-3019.
37. Lunardi C., Tiso M., Borgato L., et al. Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties. Eur J Immunol. 28:1998;936-948.
38. Loizou S., Cazabon J.K., Walport M.J., Tait D., So A.K. Similarities in specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus. Arthritis Rheum. 40:1997;103-108.
39. Reitblat T., Drogenikov T., Sigalov I., Oren S., London D. Related transient anticardiolipin antibody syndrome in a patient with parvovirus B19 infection. Am J Med. 15:(109):2000;512-513.
40. Blank M., Krause I., Fridkin M., et al. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest. 109:2002;797-804.